# Feasibility and Accuracy of Hybrid Magnetic Resonance and Positron Emission Tomography With 18F-Fluorodeoxyglucose in Diagnosing Cardiac Sarcoidosis

> **NCT03923049** · NA · TERMINATED · sponsor: **University of Alabama at Birmingham** · enrollment: 5 (actual)

## Conditions studied

- Cardiac Sarcoidosis

## Interventions

- **DIAGNOSTIC_TEST:** hybrid PET/MRI

## Key facts

- **NCT ID:** NCT03923049
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-05-21
- **Primary completion:** 2020-12-02
- **Final completion:** 2020-12-02
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Lack of funding and support
- **Last updated:** 2024-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03923049

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03923049, "Feasibility and Accuracy of Hybrid Magnetic Resonance and Positron Emission Tomography With 18F-Fluorodeoxyglucose in Diagnosing Cardiac Sarcoidosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03923049. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*